Suppr超能文献

马来酸5-[(6,7,8-三甲氧基-4-喹唑啉基)氨基]-1-戊酯硝酸盐在心血管系统中的药理特性

Pharmacological properties of 5-[(6,7,8-trimethoxy-4-quinazolinyl) amino]-1-pentanyl nitrate maleate in cardiovascular system.

作者信息

Miyamoto Y, Noguchi K, Nakasone J, Sakanashi M

机构信息

Department of Pharmacology, School of Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.

出版信息

Arzneimittelforschung. 1991 Dec;41(12):1216-21.

PMID:1815519
Abstract

Effects of 5-[6,7,8-trimethoxy-4-quinazolinyl)amino]-1-pentanyl nitrate maleate (KT-1, CAS 47487-05-8), whose chemical structure has both a prazosin and a nitrate moiety, on cardiovascular system were investigated in in vivo and in vitro experiments. KT-1 i.v. decreased aortic pressure, renal blood flow, left ventricular enddiastolic pressure and resistances of total peripheral, vertebral, coronary and renal vasculatures and increased aortic blood flow, vertebral blood flow, coronary blood flow, peak positive left ventricular dP/dt and heart rate in anesthetized open-chest dogs. These cardiovascular effects of KT-1 were similar to those of glyceryl trinitrate (nitroglycerin, GTN). Nitrate-deleted KT-1 from its chemical structure (denitro KT-1) equimolar to KT-1 produced no marked changes in these cardiovascular parameters, but 3 or 10 times large doses of denitro KT-1 showed relatively long persisting vasodilator effects. In isolated dog coronary artery preparations contracted with KCl, the order of relaxant potency was GTN greater than KT-1 greater than denitro KT-1. In isolated dog mesenteric artery preparations, phenylephrine produced concentration-dependent contractions which were significantly inhibited by prazosin and KT-1 but not by denitro KT-1. In anesthetized open-chest dogs, phenylephrine produced pressor responses which were significantly inhibited by KT-1 but not by GTN or denitro KT-1. In isolated rat thoracic aorta strips, in contrast to GTN, KT-1 hardly developed a tachyphylaxis. Thus, KT-1 showed cardiovascular effects similar to those of both nitrates and a1-adrenoceptor blocking agents with no development of a tachyphylaxis.

摘要

对化学结构中同时含有哌唑嗪和硝酸酯部分的5-[(6,7,8-三甲氧基-4-喹唑啉基)氨基]-1-戊基硝酸酯马来酸盐(KT-1,化学物质登记号47487-05-8)对心血管系统的影响进行了体内和体外实验研究。静脉注射KT-1可降低麻醉开胸犬的主动脉压、肾血流量、左心室舒张末期压力以及总外周血管、椎动脉、冠状动脉和肾血管的阻力,并增加主动脉血流量、椎动脉血流量、冠状动脉血流量、左心室压力上升最大速率峰值和心率。KT-1的这些心血管效应与硝酸甘油(GTN)相似。从其化学结构中去除硝酸酯的KT-1(去硝基KT-1)与KT-1等摩尔,对这些心血管参数无明显影响,但3倍或10倍大剂量的去硝基KT-1显示出相对持久的血管舒张作用。在氯化钾收缩的离体犬冠状动脉制剂中,舒张效力顺序为GTN>KT-1>去硝基KT-1。在离体犬肠系膜动脉制剂中,去氧肾上腺素产生浓度依赖性收缩,哌唑嗪和KT-1可显著抑制,但去硝基KT-1无此作用。在麻醉开胸犬中,去氧肾上腺素产生升压反应,KT-1可显著抑制,但GTN和去硝基KT-1无此作用。与GTN不同,在离体大鼠胸主动脉条中,KT-1几乎不产生快速耐受性。因此,KT-1显示出与硝酸盐类和α1肾上腺素受体阻断剂相似的心血管效应,且不产生快速耐受性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验